Northeast Financial Consultants’s Opus Genetics, Inc. Common Stock IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-313
| Closed | -$8K | – | 340 |
|
|
2019
Q1 | $8K | Hold |
313
| – | – | ﹤0.01% | 316 |
|
|
2018
Q4 | $14K | Buy |
+313
| New | +$14K | ﹤0.01% | 159 |
|
|
2018
Q3 | – | Sell |
-313
| Closed | -$21K | – | 177 |
|
|
2018
Q2 | $21K | Hold |
313
| – | – | 0.01% | 145 |
|
|
2018
Q1 | $22K | Hold |
313
| – | – | 0.01% | 146 |
|
|
2017
Q4 | $30K | Hold |
313
| – | – | 0.01% | 153 |
|
|
2017
Q3 | $36K | Hold |
313
| – | – | 0.01% | 150 |
|
|
2017
Q2 | $43K | Hold |
313
| – | – | 0.02% | 142 |
|
|
2017
Q1 | $76K | Hold |
313
| – | – | 0.03% | 148 |
|
|
2016
Q4 | $21K | Hold |
313
| – | – | 0.01% | 142 |
|
|
2016
Q3 | $31K | Hold |
313
| – | – | 0.01% | 154 |
|
|
2016
Q2 | $38K | Hold |
313
| – | – | 0.02% | 149 |
|
|
2016
Q1 | $50K | Hold |
313
| – | – | 0.03% | 135 |
|
|
2015
Q4 | $54K | Hold |
313
| – | – | 0.03% | 130 |
|
|
2015
Q3 | $78K | Hold |
313
| – | – | 0.04% | 139 |
|
|
2015
Q2 | $91K | Hold |
313
| – | – | 0.04% | 149 |
|
|
2015
Q1 | $109K | Hold |
313
| – | – | 0.05% | 140 |
|
|
2014
Q4 | $105K | Hold |
313
| – | – | 0.06% | 131 |
|
|
2014
Q3 | $121K | Hold |
313
| – | – | 0.07% | 130 |
|
|
2014
Q2 | $130K | Hold |
313
| – | – | 0.07% | 126 |
|
|
2014
Q1 | $162K | Buy |
+313
| New | +$162K | 0.1% | 115 |
|